Biomarkers and Cardiac CT
NCT02381301
Summary
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in developed countries. In addition, many patients suffer from valvular and aortic disease. Although various tools are available to identify patients with cardiovascular (CV) disease at risk for major adverse cardiac events (MACE), the identification of these patients remains a clinical challenge. One promising avenue is the use of different serum biomarkers involved in atherothrombosis which could provide an easy and cost-effective step in risk stratification.
Eligibility
Inclusion Criteria: * Patients referred from the Cardiology clinic for routine CCTA. Exclusion Criteria: * Pregnancy * Severe renal insufficiency * Severe allergy to contrast medium * Inability to obtain informed consent * Age below 18 years
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT02381301